Literature DB >> 19562296

Heart rate-corrected QT interval and QT dispersion in patients with pulmonary hypertension.

Zhang Hong-liang1, Luo Qin, Liu Zhi-hong, Zhao Zhi-hui, Xiong Chang-ming, Ni Xin-hai, He Jian-guo, Wei Ying-jie, Zhang Shu.   

Abstract

OBJECTIVE: Heart rate-corrected QT interval (QTc) and QTc dispersion (QTcd) are increased and associated with ventricular arrhythmia and an increase in sudden death in a variety of diseases. This study aimed to examine QTc and QTcd in pulmonary hypertension and assess their relationship with pulmonary arterial pressure. PATIENTS AND METHODS: A total of 201 patients who had undergone right heart catheterization for a preliminary diagnosis of pulmonary hypertension between December 2003 and July 2008 were included in the study. Resting 12-lead electrocardiogram was recorded. QT interval was measured manually and corrected using Bazett's formula. Patients were divided into groups with mild-to-moderate and severe pulmonary hypertension and a control group according to mean pulmonary arterial pressure.
RESULTS: In all observed cases, mean QTc was higher in severe pulmonary hypertension than in controls (428.6 +/- 32.8 ms vs. 411.1 +/- 28.4 ms, P = 0.018) and QTcd was higher in mild-to-moderate (60.1 +/- 17.2 ms) and severe pulmonary hypertension (63.9 +/- 20.5 ms) than in controls (47.3 +/- 10.6 ms) (P = 0.031; P = 0.004). In men, there was no significant difference in mean QTc and QTcd. In women, mean QTc was higher in severe pulmonary hypertension than in controls (436.1 +/- 39.4 ms vs. 407.6 +/- 24.8 ms, P = 0.037) and QTcd was higher in severe pulmonary hypertension (68.5 +/- 20.9 ms) than in both the controls (45.1 +/- 12.6 ms) and patients with mild-to-moderate pulmonary hypertension (58.6 +/- 14.7 ms) (P = 0.002; P = 0.003). In addition, in women with pulmonary hypertension, mean QTc and QTcd were positively correlated to mean pulmonary arterial pressure (r = 0.207, P = 0.03; r = 0.236, P = 0.012).
CONCLUSIONS: In women with pulmonary hypertension, mean QTc and QTcd are positively correlated to mean pulmonary arterial pressure and are significantly increased in patients with severe pulmonary hypertension.

Entities:  

Mesh:

Year:  2009        PMID: 19562296     DOI: 10.1007/s00508-009-1184-9

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  20 in total

1.  Gender differences in autonomic modulation of ventricular repolarization in humans.

Authors:  Mikiko Nakagawa; Tatsuhiko Ooie; Baiqing Ou; Masashi Ichinose; Naohiko Takahashi; Masahide Hara; Hidetoshi Yonemochi; Tetsunori Saikawa
Journal:  J Cardiovasc Electrophysiol       Date:  2005-03

2.  QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study.

Authors:  A A Naas; N C Davidson; C Thompson; F Cummings; S A Ogston; R T Jung; R W Newton; A D Struthers
Journal:  BMJ       Date:  1998-03-07

3.  Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam Study.

Authors:  M C de Bruyne; A W Hoes; J A Kors; A Hofman; J H van Bemmel; D E Grobbee
Journal:  Eur Heart J       Date:  1999-02       Impact factor: 29.983

4.  Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study.

Authors:  M Zabel; S Portnoy; M R Franz
Journal:  J Am Coll Cardiol       Date:  1995-03-01       Impact factor: 24.094

5.  Gender differences and risk of ventricular tachycardia or ventricular fibrillation.

Authors:  Mark C Haigney; Wojciech Zareba; Javed M Nasir; Scott McNitt; Douglas McAdams; Philip J Gentlesk; Robert E Goldstein; Arthur J Moss
Journal:  Heart Rhythm       Date:  2008-11-06       Impact factor: 6.343

6.  QT dispersion in sinus beats and ventricular extrasystoles in normal hearts.

Authors:  C P Day; J M McComb; R W Campbell
Journal:  Br Heart J       Date:  1992-01

7.  Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zutphen Study.

Authors:  J M Dekker; E G Schouten; P Klootwijk; J Pool; D Kromhout
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

8.  Abnormal pulmonary arterial pressure limits exercise capacity in patients with COPD.

Authors:  Karin Vonbank; Georg Christian Funk; Beatrice Marzluf; Bernhard Burian; Rolf Ziesche; Leopold Stiebellehner; Ventzislav Petkov; Paul Haber
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

9.  Effect of CPAP on QT interval dispersion in obstructive sleep apnea patients without hypertension.

Authors:  Dursun Dursunoglu; Nese Dursunoglu
Journal:  Sleep Med       Date:  2007-05-18       Impact factor: 3.492

10.  QT dispersion and sudden unexpected death in chronic heart failure.

Authors:  C S Barr; A Naas; M Freeman; C C Lang; A D Struthers
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321

View more
  14 in total

1.  COPD is not COPD is not allergy.

Authors:  Stanislav Suskovic
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

2.  Cardiac arrhythmia mechanisms in rats with heart failure induced by pulmonary hypertension.

Authors:  David Benoist; Rachel Stones; Mark J Drinkhill; Alan P Benson; Zhaokang Yang; Cecile Cassan; Stephen H Gilbert; David A Saint; Olivier Cazorla; Derek S Steele; Olivier Bernus; Ed White
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

3.  Dispersion durations of P-wave and QT interval in children with congenital heart disease and pulmonary arterial hypertension.

Authors:  Fatih Sap; Zehra Karataş; Hakan Altin; Hayrullah Alp; Bülent Oran; Tamer Baysal; Sevim Karaarslan
Journal:  Pediatr Cardiol       Date:  2012-09-13       Impact factor: 1.655

4.  QT dispersion in patients with pulmonary embolism.

Authors:  Necip Ermıs; Hilal Ermıs; Nazan Sen; Alper Kepez; Bilal Cuglan
Journal:  Wien Klin Wochenschr       Date:  2010-12-10       Impact factor: 1.704

5.  QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension.

Authors:  Jonathan D Rich; Thenappan Thenappan; Benjamin Freed; Amit R Patel; Ronald A Thisted; Rory Childers; Stephen L Archer
Journal:  Int J Cardiol       Date:  2012-03-27       Impact factor: 4.164

6.  Arrhythmogenic substrate in hearts of rats with monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.

Authors:  David Benoist; Rachel Stones; Mark Drinkhill; Olivier Bernus; Ed White
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-03-11       Impact factor: 4.733

Review 7.  Arrhythmias in pulmonary arterial hypertension.

Authors:  Archana Rajdev; Hasan Garan; Angelo Biviano
Journal:  Prog Cardiovasc Dis       Date:  2012 Sep-Oct       Impact factor: 8.194

8.  2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension.

Authors:  Chih-Hsin Hsu; Wan-Jing Ho; Wei-Chun Huang; Yu-Wei Chiu; Tsu-Shiu Hsu; Ping-Hung Kuo; Hsao-Hsun Hsu; Jia-Kan Chang; Chin-Chang Cheng; Chao-Lun Lai; Kae-Woei Liang; Shoa-Lin Lin; Hsao-Hsun Sung; Wei-Chuan Tsai; Ken-Pen Weng; Kai-Sheng Hsieh; Wei-Hsian Yin; Shing-Jong Lin; Kuo-Yang Wang
Journal:  Acta Cardiol Sin       Date:  2014-09       Impact factor: 2.672

9.  Repolarization Patterns in Congenital Heart Disease.

Authors:  Wael N Lotfy; Nashwa M Samra; Mohamed E Al Ghwass; Sayed A Amin; Sara I AboElnour
Journal:  Pediatr Cardiol       Date:  2016-06-10       Impact factor: 1.655

10.  Electrocardiography at diagnosis and close to the time of death in pulmonary arterial hypertension.

Authors:  Adriano R Tonelli; Manfred Baumgartner; Laith Alkukhun; Omar A Minai; Raed A Dweik
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-12-30       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.